Benzinga | Oct 19, 2020 09:59AM EDT

Cowen & Co. Initiates Coverage On Protara Therapeutics with Outperform Rating, Announces Price Target of $50

Cowen & Co. analyst Ken Cacciatore initiates coverage on Protara Therapeutics (NASDAQ:TARA) with a Outperform rating and announces Price Target of $50.